Related Experiment Videos
[Bronchopulmonary infections caused by Mycoplasma pneumoniae in children]
1Service de pneumologie infantile Hôpital Armand-Trousseau, Paris.
Abstract:
Mycoplasma pneumoniae, a gram-negative bacteria, is an important cause of lower respiratory tract infection in children (20% of cases). The infection tends to be endemic and is punctuated by epidemic episodes every 4 to 7 years. Its frequency seems to be higher in children between 5 and 9 years of age, but is probably underestimated before 5 years. M.pneumoniae may cause multisystem infection. Diagnosis is established upon clinical data and laboratory findings. Usually, the infection is associated with leucocyte count under 15,000/mL and C-reactive protein under 50 m/L. Detection of M. pneumoniae DNA in clinical samples appears to have advantages over serological tests. Severe infections have been described in patients with humoral and cellular immunodeficiencies, sickle cell disease, cystic fibrosis. Treatment with macrolids and tetracyclines (after 8 years of age) is indicated. Respiratory functional sequelae are possible.
Insights
Mycoplasma pneumoniae causes lower respiratory tract infections in children, often requiring diagnosis through clinical data and laboratory findings. Detecting its DNA offers advantages over serological tests for accurate diagnosis and treatment.
Area of Science:
- Bacteriology
- Pediatric Infectious Diseases
- Respiratory Medicine
Context:
- Mycoplasma pneumoniae is a significant pathogen responsible for 20% of pediatric lower respiratory tract infections.
- Infections exhibit endemic patterns with epidemic waves every 4-7 years, predominantly affecting children aged 5-9.
- The prevalence in younger children may be underestimated.
Purpose:
- To outline the epidemiology, clinical presentation, diagnostic approaches, and management of Mycoplasma pneumoniae infections in children.
- To highlight the diagnostic utility of Mycoplasma pneumoniae DNA detection.
- To identify risk factors for severe disease and potential sequelae.
Summary:
- Mycoplasma pneumoniae infections are common in children, characterized by specific laboratory findings (leukocyte count <15,000/mL, CRP <50 mg/L).
- Molecular detection of M. pneumoniae DNA is advantageous compared to serological methods.
- Severe cases occur in immunocompromised individuals and those with conditions like sickle cell disease or cystic fibrosis.
Impact:
- Informing clinical practice for accurate diagnosis and timely treatment of pediatric Mycoplasma pneumoniae infections.
- Guiding the selection of diagnostic methods, emphasizing molecular detection.
- Raising awareness of potential complications and the need for tailored management in vulnerable pediatric populations.